NIH Director's New Innovator Award (DP2 Clinical Trial Optional)
- Funder
- National Institutes of Health
- Award amount
- Up to $475,000
- Deadline
- August 19, 2027
- Eligible countries
- United States
Summary
Forecasted opportunity (not yet open for applications; expected to be posted around 2027-03-15; estimated application due date 2027-08-19). The NIH Director's New Innovator Award supports exceptionally creative early-stage investigators pursuing bold, innovative research with the potential to transform important areas of science relevant to the NIH mission. Applications are welcome across all fields relevant to NIH. The award complements other NIH programs that support early-stage investigators and is part of the NIH Common Fund's High-Risk, High-Reward Research Program.
Summary as listed on Grants.gov (opportunity 363799). Always read the full announcement for eligibility, limits and how to apply.
Read the full announcement on Grants.gov →What National Institutes of Health reviewers look for
- Importance of the research (significance and innovation), scored 1–9.
- Rigor and feasibility of the approach, scored 1–9. Preliminary data and alternative strategies carry much of this.
- Expertise and resources, rated sufficient or not, without a score.
- Overall impact: the likelihood the project will have a sustained, powerful influence on its field.
Read our guide: what funded applications do →
See how this call matches your research
Build a free research profile and Lantern Grants scores every open call against your work, tracks your deadlines and reminds you before they pass.
Get matched free